Get the Stockscreener App
3.98
1.02%
0.04
After Hours:
4.08
0.10
+2.51%
Journey Medical Corp stock is traded at $3.98, with a volume of 23,639.
It is up +1.02% in the last 24 hours and up +0.25% over the past month.
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
See More
Previous Close:
$3.94
Open:
$3.9
24h Volume:
23,639
Relative Volume:
0.23
Market Cap:
$83.14M
Revenue:
$79.89M
Net Income/Loss:
$-12.35M
P/E Ratio:
-4.7952
EPS:
-0.83
Net Cash Flow:
$32.92M
1W Performance:
+3.38%
1M Performance:
+0.25%
6M Performance:
-27.64%
1Y Performance:
-18.11%
1-Day Range:
$3.86
$4.17
1-Week Range:
$3.85
$4.3227
52-Week Range:
$2.85
$6.8899
Journey Medical Corp Stock (DERM) Company Profile
Name
Journey Medical Corp
Sector
Phone
480-434-6670
Address
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Compare DERM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
3.98 | 83.14M | 79.89M | -12.35M | 32.92M | -0.83 |
|
ZTS
Zoetis Inc
|
172.71 | 77.92B | 9.15B | 2.43B | 2.31B | 5.32 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.70 | 43.43B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
HLN
Haleon Plc Adr
|
9.57 | 43.27B | 14.26B | 1.55B | 0 | 0.3383 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.84 | 20.21B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
153.29 | 15.52B | 2.24B | 385.90M | 440.10M | 3.73 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-22-24 | Initiated | Rodman & Renshaw | Buy |
| Jun-28-24 | Resumed | ROTH MKM | Buy |
| Dec-07-21 | Initiated | B. Riley Securities | Buy |
Journey Medical Corp Stock (DERM) Latest News
Minot Light Capital’s Largest Performance Detractor in Q4: Journey Medical (DERM) - Yahoo Finance
Sara Saito’s journey from tennis courts in Gunma to promising WTA pro - The Japan Times
Stocks on brokerages’ radar for January 24 - MSN
Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea - Yahoo Finance
Journey Medical Co. (NASDAQ:DERM) Sees Significant Increase in Short Interest - MarketBeat
Journey Medical Corp (NASDAQ: DERM): Sinking Weak -28.38% In 2025, Outlook Strong - Stocks Register
Intraoperative Imaging Market: The Journey From $2.76 Billion - openPR
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Jumps 0.32 Percent In Recent Trading, What Questions Do You Have? – Stocks Register - Stocks Register
IN8bio Inc (NASDAQ: INAB): What’s Next After The Stock Plunge? - Stocks Register
CIMG Inc (NASDAQ: IMG) Stock: Bulls Should Watch This - Stocks Register
This Data Shows Just How Strong Milestone Pharmaceuticals Inc (NASDAQ: MIST) Stock Is - Stocks Register
No Stopping Allarity Therapeutics Inc (NASDAQ: ALLR)’s Stock Surged? - Stocks Register
What Do Analysts Think Will Happen To Springview Holdings Ltd (NASDAQ: SPHL) - Stocks Register
PDS Biotechnology Corporation (NASDAQ: PDSB): Hidden Gems In A Time Of Volatility - Stocks Register
Gryphon Bio, Inc. Pioneers Novel Blood Biomarker Panel to Monitor Treatment Journey for Patients with Traumatic Brain Injury and Alzheimer's - Yahoo Finance
Journey Medical Co. (NASDAQ:DERM) Shares Acquired by Geode Capital Management LLC - Defense World
DFD-29: The Journey to FDA Approval and a New Era in Rosacea Management - Dermatology Times
LAVA Therapeutics NV (LVTX)’S -5.56% Retreat Makes It Worth Considering Again - Stocks Register
Tillys Inc (TLYS): Major Improvements, Worth A Look - Stocks Register
Journey Medical (NASDAQ:DERM) Shares Down 5.3%Here's Why - MarketBeat
SWK Holdings Provides Portfolio Update - AccessWire
Malaysia’s education, business, healthcare AI journey in 2024 - The Malaysian Reserve
Step into ukiyo-e: A digital journey through Japan’s traditional art form - The Japan Times
Bridgebio’s Attruby FDA nod boosts stock; 10 November approvals - BioWorld Online
One Man Shares His Journey With ATTR-CM - Health Central
Journey Medical Decline Means Insider Profits Down To US$101k - Simply Wall St
Journey Medical Co. (NASDAQ:DERM) Sees Large Increase in Short Interest - MarketBeat
Larry Acquarulo ’81Innovates in Medical Plastics - UMass Lowell
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Position in Service Properties Trust (NASDAQ:SVC) - Defense World
Walleye Capital LLC Takes $220,000 Position in The Taiwan Fund, Inc. (NYSE:TWN) - Defense World
GE HealthCare - linkedin
Injection Perfection Medical Spa Unveils Morpheus8 OptimasMax for Comprehensive Aesthetic Treatments. - StreetInsider.com
How we help consumers eat well and support their health - Danone
Our mission - Danone
Olympic champion cyclist Remco Evenepoel says 'long journey' ahead after collision - The Japan Times
Hayabusa2 continues its journey, 10 years after launch - The Japan Times
TANG CAPITAL MANAGEMENT LLC Acquires Significant Stake in Journe - GuruFocus.com
Palmar Hyperhidrosis Pipeline Trends 2024: Clinical Trials, - openPR
Nahdi Medical Company solidifies its position as the largest primary healthcare provider in the Kingdom - ZAWYA
Journey Medical Corp (DERM) Should Be Considered For The Next Few Weeks - Stocks Register
AI Face Reshape Simulator: How It Transforms Med Spa Consultations - Perfect Corp.
One Behavioral Provider’s Decision to Co-Develop Technology - Healthcare Innovation
Women of Influence: Erica Conroy's journey from the lab to the C-SuiteColumbus Business First - The Business Journals
FY2024 EPS Estimate for Journey Medical Decreased by Analyst - MarketBeat
Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys - Yahoo Finance
FY2024 EPS Estimates for Journey Medical Boosted by B. Riley - MarketBeat
Showcasing the Journey of Researchers and Entrepreneurs at UP Manila’s Salinlohiya 2024 - University of the Philippines Manila
NY AI medical company wins global health tech competition at Scientific Sessions 2024 - American Heart Association
Advances and Challenges in Rosacea Treatment: Insights From Hilary Baldwin, MD - Dermatology Times
Journey Medical Co. (NASDAQ:DERM) Short Interest Down 20.7% in October - MarketBeat
Despite Journey Medical's Pullback, Insiders Still Gained US$118k - Yahoo Finance
Journey Medical Corp Stock (DERM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):